Automated radiosynthesis of [18F]DPA-714 on a commercially available IBA Synthera®

Amy L Vāvere,Arijit Ghosh,Victor Amador Diaz,Allison J Clay,Peter M Hall,Kiel D Neumann,Amy L. Vāvere,Allison J. Clay,Peter M. Hall,Kiel D. Neumann
DOI: https://doi.org/10.1016/j.apradiso.2024.111257
IF: 1.787
2024-05-01
Applied Radiation and Isotopes
Abstract:The goal of this work was to develop a reliable method to produce the well-validated microglial activation PET tracer, [<sup>18</sup>F]DPA-714, routinely for clinical and preclinical research using an IBA Synthera®. Optimization of literature methods included reduced precursor mass and use of TBA HCO<sub>3</sub> as the phase transfer agent in place of Kryptofix® 222 in a 65-min synthesis with an average activity yield of 24.6 ± 3.8% (n = 5). Successful quality control testing and process validation results are reported.
radiology, nuclear medicine & medical imaging,nuclear science & technology,chemistry, inorganic & nuclear
What problem does this paper attempt to address?